Pharmacological sex hormone manipulation as a risk model for depression

Vibe G Frokjaer, Vibe G Frokjaer

Abstract

Sex hormone transition may trigger severe depressive episodes in some women. In order to map mechanisms related to such phenomena we developed a pharmacological preclinical human model using sex hormone manipulation with gonadotropin releasing hormone agonist (GnRHa) in a placebo-controlled design. Here the findings from this model is synthesized and discussed in the context of related literature on hormonal contributions to reproductive mental health disorders. The GnRha model work points to an estradiol-dependent depressive response in healthy women undergoing short-term sex hormone manipulation with GnRHa, which is linked to serotonin transporter changes (a key regulator of synaptic serotonin), a disengagement of hippocampus, and overengagement of brain networks recruited when processing emotional salient information. Further, the GnRHa model suggest that key brain regions in the reward circuit are less engaged in positive stimuli when undergoing sex hormone manipulation, which may underlie anhedonia. Also, the work supports that enhanced sensitivity to estrogen signaling at the level of gene expression may drive increased risk for depressive symptoms when exposed to sex steroid hormone fluctuations. In conclusion, the GnRHa model work highlights the brain signatures of rapid and profound changes in sex steroid hormone milieu, which reflect plausible mechanisms by which risk for mood disorders works. This model points to the role of estrogen dynamics and sensitivity, and offers a rationale for personalized prevention in hormonal transition phases, for example pregnancy to postpartum transition, perimenopause, and hormone treatments, which now can move into clinical translation and ideally pave the way for protecting mental and cognitive health.

Conflict of interest statement

VGF declares that she has received honorarium as consultant for SAGE therapeutics.

© 2020 The Authors. Journal of Neuroscience Research published by Wiley Periodicals LLC.

Figures

FIGURE 1
FIGURE 1
GnRHa model study design and timings

References

    1. Amin, Z. , Gueorguieva, R. , Cappiello, A. , Czarkowski, K. A. , Stiklus, S. , Anderson, G. M. , … Epperson, C. N. (2006). Estradiol and tryptophan depletion interact to modulate cognition in menopausal women. Neuropsychopharmacology, 31, 2489–2497. 10.1038/sj.npp.1301114
    1. Barth, C. , Steele, C. J. , Mueller, K. , Rekkas, V. P. , Arelin, K. , Pampel, A. , … Sacher, J. (2016). In‐vivo dynamics of the human hippocampus across the menstrual cycle. Scientific Reports, 6, 32833 10.1038/srep32833
    1. Barth, C. , Villringer, A. , & Sacher, J. (2015). Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Frontiers in Neuroscience, 9, 37 10.3389/fnins.2015.00037
    1. Bethea, C. L. , Lu, N. Z. , Gundlah, C. , & Streicher, J. M. (2002). Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinology., 23, 41–100. 10.1006/frne.2001.0225
    1. Bixo, M. , Ekberg, K. , Poromaa, I. S. , Hirschberg, A. L. , Jonasson, A. F. , Andreen, L. , … Backstrom, T. (2017). Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)‐A randomized controlled trial. Psychoneuroendocrinology, 80, 46–55. 10.1016/j.psyneuen.2017.02.031
    1. Bloch, M. , Schmidt, P. J. , Danaceau, M. , Murphy, J. , Nieman, L. , & Rubinow, D. R. (2000). Effects of gonadal steroids in women with a history of postpartum depression. American Journal of Psychiatry, 157, 924–930. 10.1176/appi.ajp.157.6.924
    1. Bromberger, J. T. , Kravitz, H. M. , Chang, Y. F. , Cyranowski, J. M. , Brown, C. , & Matthews, K. A. (2011). Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychological Medicine, 41, 1879–1888. 10.1017/S003329171100016X
    1. Comasco, E. , Frokjaer, V. G. , & Sundstrom‐Poromaa, I. (2014). Functional and molecular neuroimaging of menopause and hormone replacement therapy. Frontiers in Neuroscience, 8, 388 10.3389/fnins.2014.00388
    1. Cooper, W. O. , Willy, M. E. , Pont, S. J. , & Ray, W. A. (2007). Increasing use of antidepressant in pregnancy. American Journal of Obstetrics and Gynecology, 196, 544–545.
    1. de Wit, A. E. , Booij, S. H. , Giltay, E. J. , Joffe, H. , Schoevers, R. A. , & Oldehinkel, A. J. (2019). Association of use of oral contraceptives with depressive symptoms among adolescents and young women. JAMA Psychiatry, 77(1), 52 10.1001/jamapsychiatry.2019.2838
    1. di Scalea, T. L. , & Wisner, K. L. (2009). Pharmacotherapy of postpartum depression. Expert Opinion on Pharmacotherapy, 10, 2593–2607. 10.1517/14656560903277202
    1. Dowlati, Y. , Ravindran, A. V. , Segal, Z. V. , Stewart, D. E. , Steiner, M. , & Meyer, J. H. (2017). Selective dietary supplementation in early postpartum is associated with high resilience against depressed mood. Proceedings of the National Academy of Sciences of the United States of America, 114, 3509–3514. 10.1073/pnas.1611965114
    1. Eisenlohr‐Moul, T. A. , DeWall, C. N. , Girdler, S. S. , & Segerstrom, S. C. (2015). Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone. Biological Psychology, 109, 37–52. 10.1016/j.biopsycho.2015.03.016
    1. Elwood, J. , Murray, E. , Bell, A. , Sinclair, M. , Kernohan, W. G. , & Stockdale, J. (2019). A systematic review investigating if genetic or epigenetic markers are associated with postnatal depression. Journal of Affective Disorders, 253, 51–62. 10.1016/j.jad.2019.04.059
    1. Evans, J. , Melotti, R. , Heron, J. , Ramchandani, P. , Wiles, N. , Murray, L. , & Stein, A. (2012). The timing of maternal depressive symptoms and child cognitive development: A longitudinal study. Journal of Child Psychology and Psychiatry, 53, 632–640. 10.1111/j.1469-7610.2011.02513.x
    1. Fellmeth, G. , Fazel, M. , & Plugge, E. (2017). Migration and perinatal mental health in women from low‐ and middle‐income countries: A systematic review and meta‐analysis. BJOG: An International Journal of Obstetrics and Gynaecology, 124, 742–752. 10.1111/1471-0528.14184
    1. Fisher, P. M. , Larsen, C. B. , Beliveau, V. , Henningsson, S. , Pinborg, A. , Holst, K. K. , … Frokjaer, V. G. (2017). Pharmacologically induced sex hormone fluctuation effects on resting‐state functional connectivity in a risk model for depression: A randomized trial. Neuropsychopharmacology, 42, 446–453. 10.1038/npp.2016.208
    1. Freeman, E. W. , Sammel, M. D. , Boorman, D. W. , & Zhang, R. (2014). Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry, 71, 36–43. 10.1001/jamapsychiatry.2013.2819
    1. Freeman, E. W. , Sammel, M. D. , Lin, H. , & Nelson, D. B. (2006). Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry, 63, 375–382. 10.1001/archpsyc.63.4.375
    1. Freeman, E. W. , Sammel, M. D. , Liu, L. , Gracia, C. R. , Nelson, D. B. , & Hollander, L. (2004). Hormones and menopausal status as predictors of depression in women in transition to menopause. Archives of General Psychiatry, 61, 62–70. 10.1001/archpsyc.61.1.62
    1. Freeman, E. W. , Sammel, M. D. , Rinaudo, P. J. , & Sheng, L. (2004). Premenstrual syndrome as a predictor of menopausal symptoms. Obstetrics and Gynecology, 103, 960–966. 10.1097/01.AOG.0000124804.81095.7f
    1. Frokjaer, V. G. , Erritzoe, D. , Juul, A. , Nielsen, F. A. , Holst, K. , Svarer, C. , … Knudsen, G. M. (2010). Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding. Psychoneuroendocrinology, 35, 1311–1320. 10.1016/j.psyneuen.2010.03.002
    1. Frokjaer, V. G. , Pinborg, A. , Holst, K. K. , Overgaard, A. , Henningsson, S. , Heede, M. , … Knudsen, G. M. (2015). Role of serotonin transporter changes in depressive responses to sex‐steroid hormone manipulation: A positron emission tomography study. Biological Psychiatry, 78, 534–543. 10.1016/j.biopsych.2015.04.015
    1. Frokjaer, V. G. , Vinberg, M. , Erritzoe, D. , Baare, W. , Holst, K. K. , Mortensen, E. L. , … Knudsen, G. M. (2010). Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding. Neuropsychopharmacology, 35, 1129–1137. 10.1038/npp.2009.218
    1. Galea, L. A. M. , & Frokjaer, V. G. (2019). Perinatal depression: Embracing variability toward better treatment and outcomes. Neuron, 102, 13–16. 10.1016/j.neuron.2019.02.023
    1. Gandal, M. J. , Haney, J. R. , Parikshak, N. N. , Leppa, V. , Ramaswami, G. , Hartl, C. , … Geschwind, D. H. (2018). Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science, 359, 693–697. 10.1126/science.aad6469
    1. Gavin, N. I. , Gaynes, B. N. , Lohr, K. N. , Meltzer‐Brody, S. , Gartlehner, G. , & Swinson, T. (2005). Perinatal depression: A systematic review of prevalence and incidence. Obstetrics and Gynecology, 106, 1071–1083. 10.1097/01.AOG.0000183597.31630.db
    1. Gordon, J. L. , Rubinow, D. R. , Eisenlohr‐Moul, T. A. , Xia, K. , Schmidt, P. J. , & Girdler, S. S. (2018). Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: A randomized clinical trial. JAMA Psychiatry, 75, 149–157. 10.1001/jamapsychiatry.2017.3998
    1. Guintivano, J. , Arad, M. , Gould, T. D. , Payne, J. L. , & Kaminsky, Z. A. (2014). Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Molecular Psychiatry, 19, 560–567. 10.1038/mp.2013.62
    1. Guintivano, J. , Manuck, T. , & Meltzer‐Brody, S. (2018). Predictors of postpartum depression: A comprehensive review of the last decade of evidence. Clinical Obstetrics and Gynecology, 61(3), 591–603. 10.1097/GRF.0000000000000368
    1. Hampson, E. , Phillips, S. D. , Duff‐Canning, S. J. , Evans, K. L. , Merrill, M. , Pinsonneault, J. K. , … Steiner, M. (2015). Working memory in pregnant women: Relation to estrogen and antepartum depression. Hormones and Behavior, 74, 218–227. 10.1016/j.yhbeh.2015.07.006
    1. Harlow, S. D. , Gass, M. , Hall, J. E. , Lobo, R. , Maki, P. , Rebar, R. W. , … de Villiers, T. J. (2012). Executive summary of the stages of reproductive aging workshop + 10: Addressing the unfinished agenda of staging reproductive aging. Journal of Clinical Endocrinology and Metabolism, 97, 1159–1168. 10.1210/jc.2011-3362
    1. Henningsson, S. , Madsen, K. H. , Pinborg, A. , Heede, M. , Knudsen, G. M. , Siebner, H. R. , & Frokjaer, V. G. (2015). Role of emotional processing in depressive responses to sex‐hormone manipulation: A pharmacological fMRI study. Translational Psychiatry, 5, e688 10.1038/tp.2015.184
    1. Hoekzema, E. , Barba‐Müller, E. , Pozzobon, C. , Picado, M. , Lucco, F. , García‐García, D. , … Vilarroya, O. (2016). Pregnancy leads to long‐lasting changes in human brain structure. Nature Neuroscience, 20, 287–296. 10.1038/nn.4458
    1. Howard, L. M. , Molyneaux, E. , Dennis, C. L. , Rochat, T. , Stein, A. , & Milgrom, J. (2014). Non‐psychotic mental disorders in the perinatal period. Lancet, 384, 1775–1788. 10.1016/S0140-6736(14)61276-9
    1. Kugaya, A. , Epperson, C. N. , Zoghbi, S. , van Dyck, C. H. , Hou, Y. , Fujita, M. , … Innis, R. B. (2003). Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. American Journal of Psychiatry, 160, 1522–1524.
    1. Lanza di Scalea, T. , & Pearlstein, T. (2019). Premenstrual dysphoric disorder. Medical Clinics of North America, 103, 613–628. 10.1016/j.mcna.2019.02.007
    1. Lokuge, S. , Frey, B. N. , Foster, J. A. , Soares, C. N. , & Steiner, M. (2011). Depression in women: Windows of vulnerability and new insights into the link between estrogen and serotonin. Journal of Clinical Psychiatry, 72, e1563–e1569. 10.4088/JCP.11com07089
    1. Lord, C. , Buss, C. , Lupien, S. J. , & Pruessner, J. C. (2008). Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: A possible window of opportunity effect. Neurobiology of Aging, 29, 95–101. 10.1016/j.neurobiolaging.2006.09.001
    1. Lu, N. Z. , Eshleman, A. J. , Janowsky, A. , & Bethea, C. L. (2003). Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques. Molecular Psychiatry, 8, 353–360. 10.1038/sj.mp.4001243
    1. Macoveanu, J. , Henningsson, S. , Pinborg, A. , Jensen, P. , Knudsen, G. M. , Frokjaer, V. G. , & Siebner, H. R. (2015). Sex‐steroid hormone manipulation reduces brain response to reward. Neuropsychopharmacology, 41(4), 1057–1065. 10.1038/npp.2015.236
    1. Macoveanu, J. , Henningsson, S. , Pinborg, A. , Jensen, P. , Knudsen, G. M. , Frokjaer, V. G. , & Siebner, H. R. (2016). Sex‐steroid hormone manipulation reduces brain response to reward. Neuropsychopharmacology, 41, 1057–1065. 10.1038/npp.2015.236
    1. Marrocco, J. , Einhorn, N. R. , Petty, G. H. , Li, H. , Dubey, N. , Hoffman, J. , … McEwen, B. S. (2018). Epigenetic intersection of BDNF Val66Met genotype with premenstrual dysphoric disorder transcriptome in a cross‐species model of estradiol add‐back. Molecular Psychiatry, 25(3), 572–583. 10.1038/s41380-018-0274-3
    1. Mehta, D. , Newport, D. J. , Frishman, G. , Kraus, L. , Rex‐Haffner, M. , Ritchie, J. C. , … Binder, E. B. (2014). Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling. Psychological Medicine, 44(11), 2309–2322. 10.1017/S0033291713003231
    1. Mehta, D. , Rex‐Haffner, M. , Sondergaard, H. B. , Pinborg, A. , Binder, E. B. , & Frokjaer, V. G. (2018). Evidence for oestrogen sensitivity in perinatal depression: Pharmacological sex hormone manipulation study. British Journal of Psychiatry, 215(3), 519–527. 10.1192/bjp.2018.234
    1. Meltzer‐Brody, S. , Boschloo, L. , Jones, I. , Sullivan, P. F. , & Penninx, B. W. (2013). The EPDS‐Lifetime: Assessment of lifetime prevalence and risk factors for perinatal depression in a large cohort of depressed women. Archives of Women's Mental Health, 16, 465–473. 10.1007/s00737-013-0372-9
    1. Meltzer‐Brody, S. , Colquhoun, H. , Riesenberg, R. , Epperson, C. N. , Deligiannidis, K. M. , Rubinow, D. R. , … Kanes, S. (2018). Brexanolone injection in post‐partum depression: Two multicentre, double‐blind, randomised, placebo‐controlled, phase 3 trials. Lancet, 392, 1058–1070. 10.1016/S0140-6736(18)31551-4
    1. Moses‐Kolko, E. L. , Berga, S. L. , Greer, P. J. , Smith, G. , Cidis Meltzer, C. , & Drevets, W. C. (2003). Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women. Fertility and Sterility, 80, 554–559. 10.1016/S0015-0282(03)00973-7
    1. Moses‐Kolko, E. L. , Berga, S. L. , Kalro, B. , Sit, D. K. , & Wisner, K. L. (2009). Transdermal estradiol for postpartum depression: A promising treatment option. Clinical Obstetrics and Gynecology, 52, 516–529. 10.1097/GRF.0b013e3181b5a395
    1. Munk‐Olsen, T. , Laursen, T. M. , Pedersen, C. B. , Mors, O. , & Mortensen, P. B. (2006). New parents and mental disorders: A population‐based register study. JAMA, 296, 2582–2589. 10.1001/jama.296.21.2582
    1. O'Hara, M. W. , & Wisner, K. L. (2014). Perinatal mental illness: Definition, description and aetiology. Best Practice & Research Clinical Obstetrics & Gynaecology, 28, 3–12. 10.1016/j.bpobgyn.2013.09.002
    1. Pearson, R. M. , Fernyhough, C. , Bentall, R. , Evans, J. , Heron, J. , Joinson, C. , … Lewis, G. (2013). Association between maternal depressogenic cognitive style during pregnancy and offspring cognitive style 18 years later. American Journal of Psychiatry, 170, 434–441. 10.1176/appi.ajp.2012.12050673
    1. Pinheiro, E. , Bogen, D. L. , Hoxha, D. , & Wisner, K. L. (2016). Transdermal estradiol treatment during breastfeeding: Maternal and infant serum concentrations. Archives of Women's Mental Health, 19, 409–413. 10.1007/s00737-015-0532-1
    1. Putnam, K. T. , Wilcox, M. , Robertson‐Blackmore, E. , Sharkey, K. , Bergink, V. , Munk‐Olsen, T. , … Meltzer‐Brody, S. (2017). Clinical phenotypes of perinatal depression and time of symptom onset: Analysis of data from an international consortium. The Lancet Psychiatry, 4(6), 477–485. 10.1016/S2215-0366(17)30136-0
    1. Rush, A. J. , Trivedi, M. H. , Wisniewski, S. R. , Nierenberg, A. A. , Stewart, J. W. , Warden, D. , … Fava, M. (2006). Acute and longer‐term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163, 1905–1917. 10.1176/ajp.2006.163.11.1905
    1. Sacher, J. , Rekkas, P. V. , Wilson, A. A. , Houle, S. , Romano, L. , Hamidi, J. , … Meyer, J. H. (2015). Relationship of monoamine oxidase‐A distribution volume to postpartum depression and postpartum crying. Neuropsychopharmacology, 40, 429–435. 10.1038/npp.2014.190
    1. Sacher, J. , Wilson, A. A. , Houle, S. , Rusjan, P. , Hassan, S. , Bloomfield, P. M. , … Meyer, J. H. (2010). Elevated brain monoamine oxidase A binding in the early postpartum period. Archives of General Psychiatry, 67, 468–474. 10.1001/archgenpsychiatry.2010.32
    1. Schmidt, P. J. , Martinez, P. E. , Nieman, L. K. , Koziol, D. E. , Thompson, K. D. , Schenkel, L. , … Rubinow, D. R. (2017). Premenstrual dysphoric disorder symptoms following ovarian suppression: Triggered by change in ovarian steroid levels but not continuous stable levels. American Journal of Psychiatry, 174, 980–989. 10.1176/appi.ajp.2017.16101113
    1. Schumann, G. , Binder, E. B. , Holte, A. , de Kloet, E. R. , Oedegaard, K. J. , Robbins, T. W. , … Wittchen, H. U. (2014). Stratified medicine for mental disorders. European Neuropsychopharmacology, 24, 5–50. 10.1016/j.euroneuro.2013.09.010
    1. Skovlund, C. W. , Morch, L. S. , Kessing, L. V. , & Lidegaard, O. (2016). Association of hormonal contraception with depression. JAMA Psychiatry, 73, 1154–1162. 10.1001/jamapsychiatry.2016.2387
    1. Sohrabji, F. (2005). Estrogen: A neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models. Annals of the New York Academy of Sciences, 1052, 75–90. 10.1196/annals.1347.006
    1. Stein, A. , Pearson, R. M. , Goodman, S. H. , Rapa, E. , Rahman, A. , McCallum, M. , … Pariante, C. M. (2014). Effects of perinatal mental disorders on the fetus and child. Lancet, 384, 1800–1819. 10.1016/S0140-6736(14)61277-0
    1. Stenbaek, D. S. , Budtz‐Jorgensen, E. , Pinborg, A. , Jensen, P. S. , & Frokjaer, V. G. (2019). Neuroticism modulates mood responses to pharmacological sex hormone manipulation in healthy women. Psychoneuroendocrinology, 99, 251–256. 10.1016/j.psyneuen.2018.10.016
    1. Stenbaek, D. S. , Fisher, P. M. , Budtz‐Jorgensen, E. , Pinborg, A. , Hjordt, L. V. , Jensen, P. S. , … Frokjaer, V. G. (2016). Sex hormone manipulation slows reaction time and increases labile mood in healthy women. Psychoneuroendocrinology, 68, 39–46. 10.1016/j.psyneuen.2016.02.023
    1. Suda, S. , Segi‐Nishida, E. , Newton, S. S. , & Duman, R. S. (2008). A postpartum model in rat: Behavioral and gene expression changes induced by ovarian steroid deprivation. Biological Psychiatry, 64, 311–319. 10.1016/j.biopsych.2008.03.029
    1. Sumner, B. E. H. , Grant, K. E. , Rosie, R. , Hegele‐Hartung, C. , Fritzemeier, K.‐H. , & Fink, G. (2007). Raloxifene blocks estradiol induction of the serotonin transporter and 5‐hydroxytryptamine2A receptor in female rat brain. Neuroscience Letters, 417(1), 95–99. 10.1016/j.neulet.2007.02.039
    1. Sundstrom Poromaa, I. , Comasco, E. , Backstrom, T. , Bixo, M. , Jensen, P. , & Frokjaer, V. G. (2018). Negative association between allopregnanolone and cerebral serotonin transporter binding in healthy women of fertile age. Frontiers in Psychology, 9, 2767 10.3389/fpsyg.2018.02767
    1. Thapar, A. , Collishaw, S. , Pine, D. S. , & Thapar, A. K. (2012). Depression in adolescence. Lancet, 379, 1056–1067. 10.1016/S0140-6736(11)60871-4
    1. Thomas, E. J. , Jenkins, J. , Lenton, E. A. , & Cooke, I. D. (1986). Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist. British Medical Journal, 293, 1407–1408. 10.1136/bmj.293.6559.1407-a
    1. WHO . (2008). The global burden of disease: 2004 update. Geneva, Switzerland: Author.
    1. Wisner, K. L. , Sit, D. K. , Moses‐Kolko, E. L. , Driscoll, K. E. , Prairie, B. A. , Stika, C. S. , … Wisniewski, S. R. (2015). Transdermal estradiol treatment for postpartum depression: A pilot randomized trial. Journal of Clinical Psychopharmacology, 35, 389–395. 10.1097/JCP.0000000000000351
    1. Yankova, M. , Hart, S. A. , & Woolley, C. S. (2001). Estrogen increases synaptic connectivity between single presynaptic inputs and multiple postsynaptic CA1 pyramidal cells: A serial electron‐microscopic study. Proceedings of the National Academy of Sciences of the United States of America, 98, 3525–3530. 10.1073/pnas.051624598
    1. Zettermark, S. , Perez Vicente, R. , & Merlo, J. (2018). Hormonal contraception increases the risk of psychotropic drug use in adolescent girls but not in adults: A pharmacoepidemiological study on 800 000 Swedish women. PLoS ONE, 13, e0194773 10.1371/journal.pone.0194773

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever